Langenfeld (rhld.) – Germany, 2023-02-16

Natural Pharma continues its successful start to the new year by expanding and deepening its partnerships to offer patients additional therapy options.

In January 2023, Natural Pharma successfully expanded its product range and now offers 400g bags of Bedrocan. The company is pleased to have already received Bedrocan pre-orders until July 2023, but unfortunately the product is sold out until then. Unfortunately, there are also certain medications that are not permanently available, which can lead to a discontinuation of therapy. However, Bedrocan will continue to be supplied by other German wholesalers to ensure that the therapy option remains continuously available for patients.

At Natural Pharma, they are proud to contribute to ensuring that patients receive continuous and reliable care. The goal is to continuously offer new, traceable, and permanently available therapy options for patients. In collaboration with our partner Beacon Medical Germany, a German subsidiary of the Canadian company VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF), Natural Pharma is achieving these goals and ensuring that the highest quality standards are met. Currently, Beacon Medical Germany is registering new medications with the IFA. By early Q3/23, additional EU-GMP products will be introduced to the market to enable further therapy options for patients.

In the future, Natural Pharma will continue to expand its therapy options by gaining additional partners and receiving medications from its partner Beacon Medical. The products from Beacon Medical Germany are exclusively grown and produced indoors at ABcann Medicinals Inc. in Napanee, Ontario, Canada. The products meet the highest quality standards, including GACP and EU-GMP at a single location. Natural Pharma is proud to offer better support to treating physicians, suffering patients, and distributing pharmacies by providing additional therapy options to enable better quality of life and sustained therapy for patients.

Natural Pharma remains committed to understanding the needs of patients. With the introduction of new products and the expansion of therapy options through partnerships such as Beacon Medical, it is on the right track to achieve this goal.

PR-Contact for Natural Pharma

Dr. Daniel König
+49 (0) 2173 940 95 91

About Natural Pharma

Natural Pharma Resource (Natural Pharma) GmbH was founded at the beginning of 2022 and is based in Langenfeld, Germany.

The pharmaceutical and biotechnological company focuses on the import, storage, manufacturing, distribution and export of pharmaceutical products, preparations and substances, in particular medicinal products under the German Medicines Act (AMG), narcotics under the German Narcotics Act (BtMG) and cannabis for medicinal purposes as well as research and development in this field.

We are licensed pharmaceutical wholesalers according to § 52a of the German Medicines Act (AMG) and have a permit to handle narcotics according to § 3 of the Federal Institute for Drugs and Medical Devices (BtMG).

For more information, visit: Natural Pharma

Our Philosophie

The company philosophy of Natural Pharma is simple. The goal is to provide patients with high quality natural and medicinal products, especially those made from cannabis plants.
Natural Pharma Resource GmbH is committed to selecting manufacturers that take into account important patient welfare criteria in order to provide an additional therapeutic option for patients with previously unsatisfactory therapeutic outcomes.
The company’s own products, partner products and also targeted products of German competitors will be offered via the Natural Pharma sales platform.

About VIVO Cannabis

VIVO Cannabis® is recognized for trusted, premium cannabis products and services. Through its Canna Farms and ABcann business units, VIVO holds production and sales licences from Health Canada and operates world-class indoor cultivation facilities. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms™, Beacon Medical®, Fireside™, and Lumina™. Harvest Medicine™, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 200,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia.
For more information, visit: VIVO Cannabis Inc. and Beacon Medical Germany.

Business partner

Become our partner and actively participate with your resources in the German cannabis market. With our in-depth understanding of the German cannabis market and our extensive experience in natural pharma, we provide you with a secure and profitable investment opportunity.

Internal forwarding: Press “Partnership” button please